RVL Pharmaceuticals plc (RVLPQ)
OTCMKTS: RVLPQ · Delayed Price · USD
0.00
0.00 (0.00%)
Jul 2, 2024, 4:00 PM EDT - Market closed
RVL Pharmaceuticals Market Cap
RVL Pharmaceuticals has a market cap or net worth of $11.14 thousand as of July 2, 2024. Its market cap has decreased by -99.99% in one year.
Market Cap
11.14K
Enterprise Value
39.00M
1-Year Change
-99.99%
Ranking
n/a
Category
Stock Price
n/a
Market Cap Chart
Since October 18, 2018, RVL Pharmaceuticals's market cap has decreased from $416.90M to $11.14K, a decrease of -100.00%. That is a compound annual growth rate of -87.79%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 20, 2023 | 2.80M | -97.48% |
Dec 30, 2022 | 111.10M | 23.58% |
Dec 31, 2021 | 89.90M | -65.14% |
Dec 31, 2020 | 257.90M | -28.95% |
Dec 31, 2019 | 363.00M | -10.81% |
Dec 31, 2018 | 407.00M | -2.37% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly | 865.41B |
Novo Nordisk | 628.46B |
UnitedHealth Group | 458.08B |
Johnson & Johnson | 351.21B |
Merck & Co. | 323.54B |
AbbVie | 294.32B |
AstraZeneca | 238.94B |
Novartis AG | 208.46B |